-+-+-+- NEXT SEGMENT -+-+-+-
Segment of length 8847
From redacted@cybernothing.org Sun Jun 12 18:00:14 2005
From: annabel soprych <redacted@advsys.co.uk>
Subject: [email] Do You Love Low-Priced Stocks?
Message-ID: <redacted@advsys.co.uk>
MIME-Version: 1.0 (Apple Message framework v553)
Content-Type: text/plain; format=flowed; charset=US-ASCII
Content-Transfer-Encoding: 7bit
Approved: redacted@cybernothing.org
Followup-To: news.admin.net-abuse.email
Newsgroups: news.admin.net-abuse.sightings
Organization: VeriMod (<URL:http://www.killfile.org/~tskirvin/verimod/>)
Processed-By: Bob the NANAS ModBot <redacted@cybernothing.org>
Verimod-Status: Sun Jun 12 18:00:14 2005 - posted
X-Auth: PGPMoose V1.1 PGP news.admin.net-abuse.sightings
iD8DBQFCrL5+v1i8LqUfqQURAouiAJ99rTDTRQloYn3CqTBjcMJBaABC0gCfYaDK
py2AGYgRwmSAo7KDHvGsCO0=
=JojB
X-Group-Homepage: http://www.killfile.org/~tskirvin/nana/
X-Mail-Path: pd3mo2so.prod.shaw.ca [UNTRUSTED]!pd3mr2so.prod.shaw.ca[UNTRUSTED]!pn2ml10so.prod.shaw.ca [10.0.121.80]!S0106000393cd80ba.vc.shawcable.net!redacted@pobox.com
X-Modbot: Bob the NANAS ModBot <redacted@cybernothing.org>
X-Original-Date: Fri, 10 Jun 2005 18:34:41 -0800
X-Original-To: redacted@pobox.com
X-Submissions-To: redacted@cybernothing.org
From redacted@advsys.co.uk Fri Jun 10 19:56:15 2005
Return-Path: <SRS0=2be6=UR=advsys.co.uk=redacted@bounce2.pobox.com>
Delivered-To: <redacted@127.0.0.1>
X-Envelope-To: <redacted@127.0.0.1>
Received: (qmail 82228 invoked from network); 11 Jun 2005 02:14:31 -0000
Received: from integer.pobox.com (208.58.1.194)
by wredhor.pair.com with SMTP; 11 Jun 2005 02:14:31 -0000
Received: from integer.pobox.com (localhost [127.0.0.1])
by integer.pobox.com (Postfix) with ESMTP id 55050FE05D
for <redacted@127.0.0.1>; Fri, 10 Jun 2005 22:14:31 -0400 (EDT)
Delivered-To: <redacted@127.0.0.1>
Received: from integer (localhost [127.0.0.1])
by integer.pobox.com (Postfix) with ESMTP id 95BEFFE078
for <redacted@127.0.0.1>; Fri, 10 Jun 2005 22:14:30 -0400 (EDT)
Received: from mx1.unit.tiscali.de
(pool-64-222-63-197.prov.east.verizon.net [64.222.63.197])
by integer.pobox.com (Postfix) with ESMTP id 66EA7FE015;
Fri, 10 Jun 2005 22:14:15 -0400 (EDT)
Received: from 30.91.237.188
by 175.198.191.79.advsys.co.uk (Postfix) with SMTP id 08003
Message-ID: <000f01c56e2b$7d7d9b40$redacted@JSEZDL>
From: "annabel soprych" <redacted@advsys.co.uk>
To: <redacted@127.0.0.1>
Subject: Do You Love Low-Priced Stocks?
Date: Fri, 10 Jun 2005 18:34:41 -0800
MIME-Version: 1.0
Content-Type: multipart/alternative;
boundary="----=_NextPart_000_000C_01C56DF0.D11EC340"
X-Priority: 3
X-MSMail-Priority: Normal
X-Mailer: Microsoft Outlook Express 6.00.2800.1158
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2800.1165
This is a multi-part message in MIME format.
------=_NextPart_000_000C_01C56DF0.D11EC340
Content-Type: text/plain;
charset="iso-8859-1"
Content-Transfer-Encoding: 7Bit
HOT SHOT STOCK ALERT
EXCITING ISSUE PGCN GET IN
NOW!!!
ONLINE OFFERING! Monday, June
13th
SYMBOL: PGCN
OTC Ticker: PGCN
Current Price: $1.01 (UP 0.49 (96.08%)
This stock is at its 52wk high today and the news is not even out yet!
Pingchuan Summary:
Harbin Pingchuan Pharmaceutical Holding Co., Ltd. ("PINGCHUAN") (PGCN)
was
established in March 2001 in Harbin city, P.R.China. It is a modernized
pharmaceutical manufacturer with first-class medical R&D ability,
pioneered
medicine products, and well-established marketing network.
Harbin Pingchuan Traditional Chinese Medicine Research Institute was
established in June 1998, with a registered capital of US$120,000.
Currently
it has 60 employees, 20 of them are professionals and experts on
diabetes.
Functioning as the R&D base of PINGCHUAN, the institute focuses on R &
D of
new medicines, particularly those on diabetes.
Since the establishment of 2001, PINGCHUAN has developed a series of
diabetes medicine, including antibiotics, chemical medical capsules and
traditional Chinese medicine. Kang Da Glycosuria Capsule is one of the
successful products of PINGCHUAN for treating diabetes. It was first
developed in 1998 and introduced to the market in 2001. PINGCHUAN also
produces medical intermediates and pharmaceutical preparations, medical
instruments, health care food and other related products.
PINGCHUAN has well-established marketing network and sale branches,
including about 180,000 retail pharmacies/drugstores across China,
agency
network in major cities like Beijing, Shanghai, Guangzhou, and Xi'an,
special sales counter at drug chain stores in key regions, residence
community clinic sale and promotion, as well as internet marketing
through
the company's website. The marketing network of PINGCHUAN covers more
than
50% districts of China and exports to US, Japan, Russia, and
south-eastern
Asia.
Example:
CWTD in February 2004 at 90 cents before it went to $8.50, an increase
of
800 PERCENT !! In March MAMA at 3.95 shortly before hitting a high of
$13.30
over 400 PERCENT !!! But We expect much more from PGCN, Sit back and
watch.
Disc:
Information
within this email contains "forwardlooking statements" within the
meaning of
Section 27Aof the Securities Act of 1933 and Section 21B of
theSecurities Exchange Act of 1934. Any statements that express or
involve discussions with respect to predictions, expectations, beliefs,
plans,projections, objectives, goals, assumptions or future events or
performance are not statements of historical fact and may be "forward
looking
statements."Forwardlooking statements are based on
expectations,estimates and projections at the time the statements are
made that involve a number of risks and uncertainties which could cause
actual results or events to differ materially from those
presently anticipated. Forward looking statements in this action may be
identified through the use of words such as"projects", "foresee",
"expects",
"will,""anticipates," "estimates," "believes," "understands"or that by
statements indicating certain actions"may," "could," or "might" occur.
Risk factors include general economic and business conditions, the
ability
to
acquire and develop specific projects, the ability to fund operations
and
changes in consumer and business consumption habits and other factors
overwhich the company has little or no control. The publisher of this
newsletter does not represent that the information contained in this
message
states all material facts or does not omit a material fact necessary to
make the statements therein not misleading. All information provided
within
this email pertaining to investing, stocks, securities must be
understood
as information provided and not investment advice. The publisher of this
newsletter advises all readers and subscribers to seek advice from
a registered professional securities representative before deciding to
trade in stocks featured within this email. None of the material within
this
report shall be construed as any kind of investment advice
or solicitation. Many of these companies are on the verge of bankruptcy.
You can lose all your money by investing in this stock. We urge you to
read
the company's SEC filings now, before you invest. The publisher of this
newsletter is not a registered investment advisor. Subscribers should
not
view information herein as legal, tax, accounting or investment
advice. In compliance with the SecuritiesAct of 1933, Section
17(b),The publisher of this newsletter is contracted to receive free
trading shares from a third party, not an officer,director or
affiliate shareholder for the circulation of this report. Be aware of an
inherent conflict of interest resulting from such compensation due to
the fact that this is a paid advertisement and is not without bias.The
party that paid us has a position in the stock they will sell at anytime
without notice.This could have a negative impact on the price of
the stock, causing you to lose money. All factual information in this
report was gathered from public sources, including but not limited to
SEC
filings,Company Websites and Company Press Releases. The publisher of
this
newsletter believes this informationto be reliable but can make no
guarantee as to its accuracy or completeness. Use of the material
within this email constitutes your acceptance of these terms.
------=_NextPart_000_000C_01C56DF0.D11EC340--
--
All postings to news.admin.net-abuse.sightings are unconfirmed and
unverified unless stated otherwise by the moderators. All opinions
expressed above are considered the opinions of the original poster,
not the moderators or their respective employers.
For a copy of the guidelines to this group, see:
http://www.killfile.org/~tskirvin/nana/
-+-+-+- NEXT SEGMENT -+-+-+-
Segment of length 8844
From redacted@cybernothing.org Sun Jun 12 18:00:14 2005
From: annabel soprych <redacted@advsys.co.uk>
Subject: [email] Do You Love Low-Priced Stocks?
Message-ID: <redacted@advsys.co.uk>
MIME-Version: 1.0 (Apple Message framework v553)
Content-Type: text/plain; format=flowed; charset=US-ASCII
Content-Transfer-Encoding: 7bit
Approved: redacted@cybernothing.org
Followup-To: news.admin.net-abuse.email
Newsgroups: news.admin.net-abuse.sightings
Organization: VeriMod (<URL:http://www.killfile.org/~tskirvin/verimod/>)
Processed-By: Bob the NANAS ModBot <redacted@cybernothing.org>
Verimod-Status: Sun Jun 12 18:00:14 2005 - posted
X-Auth: PGPMoose V1.1 PGP news.admin.net-abuse.sightings
iD8DBQFCrL5+v1i8LqUfqQURAouiAJ99rTDTRQloYn3CqTBjcMJBaABC0gCfYaDK
py2AGYgRwmSAo7KDHvGsCO0=JojB
X-Group-Homepage: http://www.killfile.org/~tskirvin/nana/
X-Mail-Path: pd3mo2so.prod.shaw.ca [UNTRUSTED]!pd3mr2so.prod.shaw.ca[UNTRUSTED]!pn2ml10so.prod.shaw.ca [10.0.121.80]!S0106000393cd80ba.vc.shawcable.net!redacted@pobox.com
X-Modbot: Bob the NANAS ModBot <redacted@cybernothing.org>
X-Original-Date: Fri, 10 Jun 2005 18:34:41 -0800
X-Original-To: redacted@pobox.com
X-Submissions-To: redacted@cybernothing.org
From redacted@advsys.co.uk Fri Jun 10 19:56:15 2005
Return-Path: <SRS0=2be6=UR=advsys.co.uk=redacted@bounce2.pobox.com>
Delivered-To: <redacted@127.0.0.1>
X-Envelope-To: <redacted@127.0.0.1>
Received: (qmail 82228 invoked from network); 11 Jun 2005 02:14:31 -0000
Received: from integer.pobox.com (208.58.1.194)
by wredhor.pair.com with SMTP; 11 Jun 2005 02:14:31 -0000
Received: from integer.pobox.com (localhost [127.0.0.1])
by integer.pobox.com (Postfix) with ESMTP id 55050FE05D
for <redacted@127.0.0.1>; Fri, 10 Jun 2005 22:14:31 -0400 (EDT)
Delivered-To: <redacted@127.0.0.1>
Received: from integer (localhost [127.0.0.1])
by integer.pobox.com (Postfix) with ESMTP id 95BEFFE078
for <redacted@127.0.0.1>; Fri, 10 Jun 2005 22:14:30 -0400 (EDT)
Received: from mx1.unit.tiscali.de
(pool-64-222-63-197.prov.east.verizon.net [64.222.63.197])
by integer.pobox.com (Postfix) with ESMTP id 66EA7FE015;
Fri, 10 Jun 2005 22:14:15 -0400 (EDT)
Received: from 30.91.237.188
by 175.198.191.79.advsys.co.uk (Postfix) with SMTP id 08003
Message-ID: <000f01c56e2b$7d7d9b40$redacted@JSEZDL>
From: "annabel soprych" <redacted@advsys.co.uk>
To: <redacted@127.0.0.1>
Subject: Do You Love Low-Priced Stocks?
Date: Fri, 10 Jun 2005 18:34:41 -0800
MIME-Version: 1.0
Content-Type: multipart/alternative;
boundary="----=_NextPart_000_000C_01C56DF0.D11EC340"
X-Priority: 3
X-MSMail-Priority: Normal
X-Mailer: Microsoft Outlook Express 6.00.2800.1158
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2800.1165
This is a multi-part message in MIME format.
------=_NextPart_000_000C_01C56DF0.D11EC340
Content-Type: text/plain;
charset="iso-8859-1"
Content-Transfer-Encoding: 7Bit
HOT SHOT STOCK ALERT
EXCITING ISSUE PGCN GET IN
NOW!!!
ONLINE OFFERING! Monday, June
13th
SYMBOL: PGCN
OTC Ticker: PGCN
Current Price: $1.01 (UP 0.49 (96.08%)
This stock is at its 52wk high today and the news is not even out yet!
Pingchuan Summary:
Harbin Pingchuan Pharmaceutical Holding Co., Ltd. ("PINGCHUAN") (PGCN)
was
established in March 2001 in Harbin city, P.R.China. It is a modernized
pharmaceutical manufacturer with first-class medical R&D ability,
pioneered
medicine products, and well-established marketing network.
Harbin Pingchuan Traditional Chinese Medicine Research Institute was
established in June 1998, with a registered capital of US$120,000.
Currently
it has 60 employees, 20 of them are professionals and experts on
diabetes.
Functioning as the R&D base of PINGCHUAN, the institute focuses on R &
D of
new medicines, particularly those on diabetes.
Since the establishment of 2001, PINGCHUAN has developed a series of
diabetes medicine, including antibiotics, chemical medical capsules and
traditional Chinese medicine. Kang Da Glycosuria Capsule is one of the
successful products of PINGCHUAN for treating diabetes. It was first
developed in 1998 and introduced to the market in 2001. PINGCHUAN also
produces medical intermediates and pharmaceutical preparations, medical
instruments, health care food and other related products.
PINGCHUAN has well-established marketing network and sale branches,
including about 180,000 retail pharmacies/drugstores across China,
agency
network in major cities like Beijing, Shanghai, Guangzhou, and Xi'an,
special sales counter at drug chain stores in key regions, residence
community clinic sale and promotion, as well as internet marketing
through
the company's website. The marketing network of PINGCHUAN covers more
than
50% districts of China and exports to US, Japan, Russia, and
south-eastern
Asia.
Example:
CWTD in February 2004 at 90 cents before it went to $8.50, an increase
of
800 PERCENT !! In March MAMA at 3.95 shortly before hitting a high of
$13.30
over 400 PERCENT !!! But We expect much more from PGCN, Sit back and
watch.
Disc:
Information
within this email contains "forwardlooking statements" within the
meaning of
Section 27Aof the Securities Act of 1933 and Section 21B of
theSecurities Exchange Act of 1934. Any statements that express or
involve discussions with respect to predictions, expectations, beliefs,
plans,projections, objectives, goals, assumptions or future events or
performance are not statements of historical fact and may be "forward
looking
statements."Forwardlooking statements are based on
expectations,estimates and projections at the time the statements are
made that involve a number of risks and uncertainties which could cause
actual results or events to differ materially from those
presently anticipated. Forward looking statements in this action may be
identified through the use of words such as"projects", "foresee",
"expects",
"will,""anticipates," "estimates," "believes," "understands"or that by
statements indicating certain actions"may," "could," or "might" occur.
Risk factors include general economic and business conditions, the
ability
to
acquire and develop specific projects, the ability to fund operations
and
changes in consumer and business consumption habits and other factors
overwhich the company has little or no control. The publisher of this
newsletter does not represent that the information contained in this
message
states all material facts or does not omit a material fact necessary to
make the statements therein not misleading. All information provided
within
this email pertaining to investing, stocks, securities must be
understood
as information provided and not investment advice. The publisher of this
newsletter advises all readers and subscribers to seek advice from
a registered professional securities representative before deciding to
trade in stocks featured within this email. None of the material within
this
report shall be construed as any kind of investment advice
or solicitation. Many of these companies are on the verge of bankruptcy.
You can lose all your money by investing in this stock. We urge you to
read
the company's SEC filings now, before you invest. The publisher of this
newsletter is not a registered investment advisor. Subscribers should
not
view information herein as legal, tax, accounting or investment
advice. In compliance with the SecuritiesAct of 1933, Section
17(b),The publisher of this newsletter is contracted to receive free
trading shares from a third party, not an officer,director or
affiliate shareholder for the circulation of this report. Be aware of an
inherent conflict of interest resulting from such compensation due to
the fact that this is a paid advertisement and is not without bias.The
party that paid us has a position in the stock they will sell at anytime
without notice.This could have a negative impact on the price of
the stock, causing you to lose money. All factual information in this
report was gathered from public sources, including but not limited to
SEC
filings,Company Websites and Company Press Releases. The publisher of
this
newsletter believes this informationto be reliable but can make no
guarantee as to its accuracy or completeness. Use of the material
within this email constitutes your acceptance of these terms.
------=_NextPart_000_000C_01C56DF0.D11EC340--
--
All postings to news.admin.net-abuse.sightings are unconfirmed and
unverified unless stated otherwise by the moderators. All opinions
expressed above are considered the opinions of the original poster,
not the moderators or their respective employers.
For a copy of the guidelines to this group, see:
http://www.killfile.org/~tskirvin/nana/